AI assistant
Sending…
CASSAVA SCIENCES INC — Director's Dealing 2025
Nov 20, 2025
33903_dirs_2025-11-20_c63a14b3-5a30-4af6-ad7c-2f4dbeb31134.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CASSAVA SCIENCES INC (SAVA)
CIK: 0001069530
Period of Report: 2025-11-19
Reporting Person: Barry Richard (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-19 | Common Stock | P | 73385 | $2.75 | Acquired | 788060 | Indirect |
Footnotes
F1: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $2.73 to $2.75 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.
More from CASSAVA SCIENCES INC
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Feb 19
Regulatory Filings
2025
Dec 23
Regulatory Filings
2025
Dec 22
Regulatory Filings
2025
Dec 18
Regulatory Filings
2025
Dec 17
Regulatory Filings
2025
Dec 8
Prospectus
2025
Dec 5